Bod Science Limited
Bod Science Limited (BOD.AX) Financial Performance & Income Statement Overview
Review Bod Science Limited (BOD.AX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Bod Science Limited (BOD.AX) Income Statement & Financial Overview
Explore comprehensive income reports for Bod Science Limited BOD.AX, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $440451.00 | $1.08M | $1.08M | $586354.00 |
| Cost of Revenue | $459854.00 | $210458.00 | $210458.00 | $2.20M |
| Gross Profit | -$19403.00 | $865500.00 | $865500.00 | -$1.61M |
| Gross Profit Ratio | -$0.04 | $0.80 | $0.80 | -$2.75 |
| R&D Expenses | $62302.00 | $572010.00 | $572010.00 | $1.88M |
| SG&A Expenses | $1.06M | $1.13M | $1.13M | $1.53M |
| Operating Expenses | $306380.00 | $1.70M | $1.70M | $3.17M |
| Total Costs & Expenses | $766238.00 | $1.91M | $1.91M | $5.37M |
| Interest Income | $12012.00 | $0.00 | $0.00 | $10562.00 |
| Interest Expense | $49115.00 | $0.00 | $0.00 | $27351.00 |
| Depreciation & Amortization | $72585.00 | $136320.00 | $13873.00 | $82525.00 |
| EBITDA | -$515101.00 | -$1.49M | -$1.49M | -$4.67M |
| EBITDA Ratio | -$1.17 | -$1.39 | -$1.39 | -$7.97 |
| Operating Income | -$325787.00 | -$833145.00 | -$833145.00 | -$4.78M |
| Operating Income Ratio | -$0.74 | -$0.77 | -$0.77 | -$8.16 |
| Other Income/Expenses (Net) | -$311018.00 | -$2.24M | -$2.24M | $971.00 |
| Income Before Tax | -$636805.00 | -$3.07M | -$3.07M | -$4.78M |
| Income Before Tax Ratio | -$1.45 | -$2.85 | -$2.85 | -$8.15 |
| Income Tax Expense | -$363865.00 | -$1.62M | $0.00 | $0.00 |
| Net Income | -$272940.00 | -$3.07M | -$3.07M | -$4.78M |
| Net Income Ratio | -$0.62 | -$2.85 | -$2.85 | -$8.15 |
| EPS | -$0.002 | -$0.02 | -$0.02 | -$0.03 |
| Diluted EPS | -$0.002 | -$0.02 | -$0.02 | -$0.03 |
| Weighted Avg Shares Outstanding | $177.34M | $171.24M | $171.03M | $153.03M |
| Weighted Avg Shares Outstanding (Diluted) | $177.34M | $171.24M | $171.24M | $153.02M |
Over the last four quarters, Bod Science Limited's revenue moved from $586354.00 in Q4 2023 to $440451.00 in Q4 2024. Operating income in Q4 2024 was -$325787.00, with a strong operating margin of -74%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Bod Science Limited remained robust at -$515101.00, reflecting operational efficiency. Net income rose to -$272940.00, with an EPS of -$0.002. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan